Q4 EPS Estimates for DENTSPLY SIRONA Cut by Leerink Partnrs

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for shares of DENTSPLY SIRONA in a research note issued to investors on Thursday, November 7th. Leerink Partnrs analyst M. Cherny now anticipates that the medical instruments supplier will earn $0.44 per share for the quarter, down from their prior estimate of $0.58. Leerink Partnrs currently has a “Hold” rating on the stock. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s Q1 2025 earnings at $0.40 EPS, Q2 2025 earnings at $0.50 EPS, Q3 2025 earnings at $0.54 EPS, Q4 2025 earnings at $0.54 EPS, FY2025 earnings at $1.98 EPS, FY2026 earnings at $2.32 EPS and FY2027 earnings at $2.60 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same period in the prior year, the business earned $0.49 EPS. The company’s revenue for the quarter was up .4% compared to the same quarter last year.

Several other brokerages have also recently weighed in on XRAY. Barrington Research dropped their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Robert W. Baird dropped their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Evercore ISI dropped their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Finally, Stifel Nicolaus dropped their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $29.50.

DENTSPLY SIRONA Trading Up 0.7 %

Shares of XRAY stock opened at $17.77 on Monday. The stock has a market capitalization of $3.60 billion, a PE ratio of -8.58, a P/E/G ratio of 0.97 and a beta of 1.02. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $37.60. The business has a 50-day moving average of $24.38 and a 200 day moving average of $25.65. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.87.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. First Eagle Investment Management LLC raised its position in shares of DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after acquiring an additional 3,283,965 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of DENTSPLY SIRONA by 42.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after acquiring an additional 1,308,411 shares in the last quarter. Cooke & Bieler LP raised its position in shares of DENTSPLY SIRONA by 16.2% in the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after acquiring an additional 1,046,105 shares in the last quarter. Edmond DE Rothschild Holding S.A. raised its position in shares of DENTSPLY SIRONA by 398.2% in the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 1,025,200 shares of the medical instruments supplier’s stock worth $34,026,000 after acquiring an additional 819,400 shares in the last quarter. Finally, Jupiter Asset Management Ltd. raised its position in shares of DENTSPLY SIRONA by 505.7% in the 1st quarter. Jupiter Asset Management Ltd. now owns 937,084 shares of the medical instruments supplier’s stock worth $31,102,000 after acquiring an additional 782,362 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.